Latest News

MBM ScienceBridge GmbH successfully negotiated a license agreement between Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin (UMG) and the biotech company Repairon GmbH about commercial production and use of engineered human myocardium for heart...

Read more

One of the most common acquired heart diseases in the over 75’s is aortic valve stenosis. Normally, it requires the replacement of the valve. In principle, there are two ways to do this: the patient’s thorax is opened surgically and an artificial valve is implanted; or a new...

Read more

Signal molecules called chemokines often work in tandem to recruit specific sets of immune cells to sites of tissue damage. A systematic analysis of their interactions by LMU researchers and DZHK-Scientists pinpoints potential targets for new therapies.

Read more

A current evaluation of seven population-based studies in Germany reveals that blood pressure in Germany has decreased in the last two decades. The greatest decrease was seen in 55 to 74 year-olds. Despite the decrease, blood pressure in Germany is still too high. Particularly...

Read more

The molecule microRNA-210 stabilises deposits in the carotid artery and can thus prevent them from tearing, and prevent dangerous blood clots from forming. This is what scientists headed by Prof. Lars Mägdefessel, Professor of Vascular Biology at the Technical University of...

Read more